Purpose: The aim was to evaluate the added value of 18F-FDG PET/CT in initial staging of pediatric Rhabdomyosarcoma patients in comparison to other conventional images. Materials and methods: This is a retrospective study including total 112 patients with pathologically proven RMS (52 female, 60 males; mean age, 5.8 years, with predominant embryonal type), Results of PET/CT were compared with computed tomography and/or MRI. Max SUV of the primary lesion, lymph nodes and distant metastases were evaluated in an individual and lesion analysis. Clinical follow-up (mean 27 months), and histo-pathological data were served as the standard of reference. Results: Among 112 patients, 45 (40%) patients proved metastatic by PET/CT, and 5 was Indeterminate. For primary tumor site, both diagnostic CT and FDG PET/CT show comparable results. Extremities were the most common primary site in metastatic patients & Alveolar type was more prevalent pathology among metastatic patients. Initial PET/CT upstages 13 patients (11.6%). Additional 50 lesions were determinate by PET/CT (21 nodal, 16 osseous, 3 peritoneal, 5 soft tissue nodules, 5 bone marrow involvement).Unusual site of metastases were detected by both modalities, includes suprarenal, spermatic cord and IVC thrombosis in individual patients .The sensitivity and PPV for PET/CT were higher than CT for nodal, osseous, soft tissue & peritoneal metastases. 26 Conclusion: The current study showed that 18FDG-PET/CT is useful in initial staging of RMS patients as compared to CT regarding nodal, bone, bone marrow, soft tissue and peritoneal metastatic lesions, except for pulmonary deposits.
INTRODUCTION:
Soft tissue sarcomas account for 6%-10% of all childhood malignancies.
Rhabdomyosarcoma (RMS) constitutes for over 50% of these in children and young adult (1, 2) . The presence of distant metastases is the strongest predictor factor for clinical outcomes in patients with RMS together with tumor size and invasiveness, primary site, age of the patient and different pathological differentiation (3) .
The last 30 years shows increased eventfree survival (EFS) and overall survival (OS) from 25% in 1970 to 70%, in patients with RMS, refereed to the improvement of risk stratification and multimodality therapy protocol. Despite this improvement, 5-year EFS for patients with distant metastasis are still 25% (4, 5) . So the assessment of metastatic disease at staging accurate tumor localization for more confident interpretation (6) .
The aim of this study was to clarify the role of F18-FDG PET/CT in the initial staging of Rhabdomyosarcoma compared with other conventional imaging. Tables (2). PET/CT upstaged 13 (11.6%) patients as it Figure (1 Table ( Initial PET/CT shows multiple metastatic pleuro-pulmonary, nodal and osseous deposits. . However in our study, additional 50 lesions were detected by PET/CT that was not appreciated on CT. In agreement with other few studies, PET/CT was superior to CT for the identification of bone lesions, either in detection of additional lesion or in changing patient's stage (12, 13) .
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RESULTS
PET/CT may also have potential to identify marrow involvement.
The advantage of conducting a whole body scan is highlighting the limitations of relying on histopathology obtained from a single site (5, 6) .
The enumerated bony lesions were demonstrated only by the increased FDG activity on PET scan without any sclerotic/lytic CT changes.
There were indications that PET/CT may perform better than conventional imaging in detecting soft-tissue lesions in nonpulmonary locations (9, 10) . These results accord with reviews of PET-CT in staging of osteosarcoma and PET in general diagnosis of pulmonary nodules (14, 15) .
In spite of the favored sensitivity for PET/CT in M staging, 98%, its sensitivity for lung metastases was ~92%. This agrees with the findings of previously reported studies showing that FDG PET is not able to adequately assess lung metastases smaller than ~ 6 mm.
It could be generated from respiratory motion artifacts or from the low metabolic activity of the small sized lung metastases not detected by the limited spatial resolution of PET.
It is well known that CT has a better accuracy for the detection of lung metastases, especially in children, due to the lower probability of unspecific nodules in children than in adults (16) .
The limitation of this study, was its retrospective nature so, was not adequately designed as a comparative imaging study, for example MRI was the 1st choice for the primary tumor, CT for the detection of distant metastases, yet, bone scan was not done in all patients.
Second, lymph node biopsy was not feasible in all patients so was assessed by increase in number and/or an apparent progression in size on follow up examinations.
CONCLUSION:
FDG PET-CT is helpful in initial staging of Rhabdomyosarcoma patients as compared to Diagnostic CT regarding nodal, bone, bone marrow, peritoneum, and soft tissue metastatic lesions, except for pulmonary deposits.
